Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs SPDR Gold Trust (GLD) Price & Performance

Ascendis Pharma A/STrade
SPDR Gold TrustTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs SPDR Gold Trust — how do they compare? Ascendis Pharma A/S trades at $254 (market cap $16.67B), while SPDR Gold Trust trades at $404.75. The key difference: Ascendis Pharma A/S is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals.

ASNDGLD
Market Cap
$16.67B
Sector
Health
52-Week High
$277.18$495.90
52-Week Low
$189.74$305.27
Enterprise Value
$17.04B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About SPDR Gold Trust

GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.

Read more on GLD